Prodisc C Vivo
Device Spine Implant
General payments
$710,101
Research payments
$7,516,577
Through program year 2025, $710,101 in general payments and $7,516,577 in research payments were reported against Prodisc C Vivo (Spine Implant).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
12 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $26,924 | 197 |
| 2025 | Research | $516,706 | 169 |
| 2024 | General | $33,726 | 186 |
| 2024 | Research | $880,139 | 257 |
| 2023 | General | $116,138 | 363 |
| 2023 | Research | $2,975,254 | 353 |
| 2022 | General | $136,406 | 164 |
| 2022 | Research | $2,392,469 | 257 |
| 2020 | General | $85,251 | 142 |
| 2020 | Research | $459,355 | 81 |
| 2019 | General | $311,656 | 123 |
| 2019 | Research | $292,655 | 9 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 31 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
1,175 general · 1,126 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.